Mr. Schachter founded Reedland in 1997 and has over 30 years of capital markets and investment banking experience. He has arranged financing transactions with a value in excess of several billion dollars over his career, with a particular focus on financing life science companies. Mr. Schachter also acts as an advisor to Ricanto Ltd, a privately held, UK-based pharmaceutical asset optimization company.

Prior to founding Reedland, Mr. Schachter was a Managing Director at Shoreline Pacific Institutional Finance from 1995 to 1998, where he was responsible for structuring and negotiating more than $750M in private equity financings for publicly-listed emerging growth companies. In 1991, he became VP of Sales at Lehman Brothers, where he was responsible for servicing and managing institutional bond accounts. Mr. Schachter joined Wharton Capital as Senior VP in 1990, where he was responsible for securing secondary debt, raising equity capital and identifying prospective acquisition candidates. In 1986, he joined Smith Barney, Harris Upham & Co. as VP of Retail Sales. Mr. Schachter began his investment career in 1983 at Paine Webber, Inc., where he became one of the youngest satellite office managers in the firm’s history, assisted with private placement transactions for a number of the country’s pioneer biotechnology companies and traded securities for his clients in the secondary market.

Mr. Schachter is a Series 24 (General Securities Principal) and Series 7 (General Securities Representative) registrant.

Away from the office, Rob enjoys spending time with his family, hiking with his Italian mastiff, music, cooking and classic cars.